MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
19.43
+0.92 (4.97%)
Mar 9, 2026, 1:57 PM EDT - Market open
MapLight Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 14.04 | 14.42 | 7.61 | 4.1 |
| Research & Development | 94.44 | 68.52 | 49.68 | 27.14 |
| Operating Expenses | 108.48 | 82.95 | 57.28 | 31.25 |
| Operating Income | -108.48 | -82.95 | -57.28 | -31.25 |
| Interest & Investment Income | 3.95 | 4.5 | 1.1 | 0.43 |
| Earnings From Equity Investments | - | -0.99 | 0.99 | - |
| Currency Exchange Gain (Loss) | - | - | - | 0 |
| Other Non Operating Income (Expenses) | 2.38 | 1.85 | -0.51 | 0.8 |
| Pretax Income | -102.83 | -77.58 | -55.71 | -30.02 |
| Net Income | -102.83 | -77.58 | -55.71 | -30.02 |
| Net Income to Common | -102.83 | -77.58 | -55.71 | -30.02 |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 |
| Shares Change (YoY) | 15.66% | 11.60% | 18.43% | - |
| EPS (Basic) | -133.73 | -105.38 | -84.45 | -53.89 |
| EPS (Diluted) | -133.73 | -105.38 | -84.45 | -53.89 |
| Free Cash Flow | -113 | -79.59 | -52.47 | -27.32 |
| Free Cash Flow Per Share | -146.95 | -108.10 | -79.54 | -49.05 |
| EBITDA | -107.85 | -82.25 | -56.73 | -30.67 |
| D&A For EBITDA | 0.63 | 0.7 | 0.56 | 0.57 |
| EBIT | -108.48 | -82.95 | -57.28 | -31.25 |
Source: S&P Capital IQ. Standard template.
Financial Sources.